Patient Leaflet Updated 03-Jun-2025 | Baxter Healthcare Ltd
Mannitol 10% Solution for Infusion BP
Mannitol 10% Solution for infusion BP
Mannitol 10% Infusion
Active substance: mannitol
This medicine is called `Mannitol 10% Solution for Infusion BP´ but will be referred to as `Mannitol 10% Infusion´ throughout the remainder of this leaflet.
1. What Mannitol 10% Infusion is and what it is used for.
2. What do you need to know before you are given Mannitol 10% Infusion.
3. How you will be given Mannitol 10% Infusion.
4. Possible side effects.
5. How to store Mannitol 10% Infusion.
6. Contents of the pack and other information.
Mannitol 10% Infusion is a solution of mannitol in water.
Mannitol 10% Infusion is used to:
Please tell your doctor if you have, or have had, any of the following medical conditions:
When monitoring is required, your doctor may want to carry out tests to ensure that your dose is sufficient.
These tests may include:
This solution should not be given through the same needle as a blood transfusion. This can damage the red blood cells or cause them to clump together.
Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.
The following medicines are known to affect or be affected by Mannitol 10% Infusion. Please tell your doctor if you are taking any of these medicines:
You should ask your doctor about what you can eat or drink.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before taking this medicine.
It is not known whether mannitol could affect your unborn baby or your pregnancy. It is also not known whether mannitol could reach your baby through your breast milk. Your doctor will therefore only give you Mannitol 10% Infusion, during pregnancy or breast-feeding, if it is essential.
Ask your doctor or nurse for advice before driving or using machines.
Your doctor will decide on how much you need and when it is to be given. The dose to be given is always governed by your individual requirements. Mannitol 10% Infusion will usually be given to you through a plastic tube attached to a needle, in a vein. If your kidneys are not working properly, your doctor may give you a test dose of the infusion. The amount of urine you produce will then be measured.
Mannitol 10% Infusion can also be used in children and in the elderly (over 65 years of age). Your doctor will adjust the dose as necessary.
You should NOT be given Mannitol 10% Infusion if there are particles floating in the solution or if the pack is damaged in any way.
Crystals may form in the solution when exposed to low temperatures. Your doctor or nurse will ensure that these crystals have been resorbed before they administer the solution.
If you are given too much Mannitol 10% Infusion (over-infusion) or if it is given too fast, this may lead to the following symptoms:
If you develop any of these symptoms, you must inform your doctor immediately. Your infusion will be stopped and you will be given treatment, depending on the symptoms.
If a medication has been added to Mannitol 10%, you should read the Package Leaflet of the added medicine for a list of possible symptoms.
Your doctor will decide when to stop giving you this infusion.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, Mannitol 10% Infusion can cause side effects, although not everybody gets them.
These may be signs of a very severe or even fatal allergic reaction called anaphylactic shock:
You will be given treatment depending on the symptoms.
Other side effects, which you may experience, include:
If you get any side effects, talk to your doctor or pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed below. By reporting side effects, you can help provide more information on the safety of this medicine.
United Kingdom:
Via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard
Ireland:
This product should not be refrigerated or frozen.
Keep this medicine out of the sight and reach of children.
Do not remove Mannitol 10% Infusion from the outer plastic bag until it is to be used.
Mannitol 10% Infusion should NOT be given to you after the expiry date which is stated on the bag after EXP. The expiry date refers to the last day of that month.
After opening, with or without additives:
From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user.
You should not be given Mannitol 10% Infusion if there are particles floating in the solution or if the unit is damaged in any way.
The active substance is mannitol.
The only other ingredient is water for injections.
Each 1000 ml of solution contains 100 grams of mannitol.
Mannitol 10% Infusion is a clear solution, free from visible particles. It is supplied in polyolefin/polyamide plastic bags (Viaflo). Each bag is wrapped in a sealed, protective, outer plastic overpouch.
The bag sizes are:
The bags are supplied in cartons. Each carton contains one of the following quantities:
Not all pack sizes may be marketed.
Marketing Authorisation Holder :
United Kingdom:
Republic of Ireland:
Manufacturers for Great Britain:
Manufacturers for Ireland:
This leaflet was last revised in September 2024
For information about Mannitol 10% Infusion or to request this leaflet in formats such as audio or large print please contact the Marketing Authorisation Holder:
Tel: +44 (0)1635 206345.
Baxter and Viaflo are trademarks of Baxter International Inc.
TH-30-02-251
Caxton Way, Thetford, Norfolk, IP24 3SE, UK
0800 0260516
https://medinfo.baxterhealthcare.co.uk
https://www.baxterhealthcare.co.uk/
0800 028 9881